The size of the Defibrillators Market in the Middle East & Africa was around USD 0.77 Billion in 2023 and is expected to grow at a CAGR of 5.4% to reach USD 1.00 billion by 2028.
Increasing adoption of technologically advanced defibrillators and an increase in the incidence of CVDs, and an aging population with an increased risk of targeted illnesses are some of the major factors driving demand for defibrillators in the MEA.
CRT-Ds that are MRI compatible are expected to give growing opportunities for developing and emerging economies. Moreover, the public and commercial organizations are focusing on developing new technologies in the medical industry. The number of training institutes is increasing, all of which are encouraging market growth.
Increasing investment and funding by the government to improve the quality of diagnostic and treatment processes and rising urbanization and disposable income are likely to boost the Middle East defibrillators market growth during the forecast period. In addition, during the Covid-19 pandemic, the international liaison committee on cardiopulmonary resuscitation modified the resuscitation guidelines, ensuring enhanced defibrillation delivery through increased healthcare worker training and decreasing uncertainty in pandemic resuscitation efforts.
Furthermore, the increased concern for quality treatment methods and improving patient health and changes in food choices, and the adoption of sedentary lifestyles indirectly contribute to the defibrillator market in the Middle East and Africa.
A shortage of qualified personnel who can run and analyze systems more efficiently slows the market's growth rate. Lack of consistency, failure of real-time operations, and technicians' lack of expertise in handling issues are all constraints to market growth. Furthermore, these systems necessitate significant deployment and maintenance, which is a substantial burden to healthcare professionals.
This research report on the Middle East and Africa defibrillators market has been segmented and sub-segmented into the following categories:
By End User:
Regionally, the MEA region is capturing around 3% of the global defibrillators market. The market growth is majorly driven by the supportive legislative reforms, increased occurrences of sudden cardiac arrests in the region, integrated technologies, and rising awareness for cardiac disorders. Furthermore, the pandemic heightened the need for defibrillators since many older people suffering from viral infection experienced abrupt cardiac arrests, making the device useful for resuscitation. Due to supportive healthcare infrastructure and broader adoption of technologically advanced devices, the Middle East and Africa held the most significant revenue share in 2020. On the other hand, due to the existence of expanding economies such as the United Arab Emirates and Kuwait and rising healthcare expenditure, the market in the Middle East and Africa is expected to grow.
South Africa held the largest share of the MEA defibrillators market and is projected to witness the largest share of the market during the forecast period owing to the improving healthcare infrastructure, technological advancements, and growing healthcare expenditure. In addition, increased public awareness of the availability of various treatment techniques, growing government assistance to improve the quality of diagnostic and treatment processes, and increasing urbanization and disposable income are likely to boost the defibrillator market.
On the other hand, emerging countries such as UAE and Saudi Arabia are projected to record a promising share and contribute to the MEA regional market growth. The increasing need for both implanted and external defibrillators, increasing healthcare spending, healthcare infrastructure, and innovative products are fuelling the market growth.
KEY MARKET PLAYERS:
Medtronic PLC (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), LivaNova PLC (U.K.), Koninklijke Philips N.V. (Netherlands), ZOLL Medical Corporation (U.S.), Cardiac Science Corporation (U.S.), Physio-Control, Inc. (U.S.), and Nihon Kohden Corporation (Japan) are some of the notable companies operating in the MEA defibrillators market.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org